These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 9322970

  • 1. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
    Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T.
    Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.
    Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M, Perricaudet M.
    Cancer Res; 2000 Jul 01; 60(13):3484-92. PubMed ID: 10910060
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW, Schröder-van der Elst JP, Karperien M, Que I, Stokkel M, van der Heide D, Romijn JA.
    J Clin Endocrinol Metab; 2002 Mar 01; 87(3):1247-53. PubMed ID: 11889195
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Cancer Res; 2000 Nov 15; 60(22):6526-30. PubMed ID: 11103823
    [Abstract] [Full Text] [Related]

  • 7. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
    Spitzweg C, Joba W, Morris JC, Heufelder AE.
    Thyroid; 1999 Aug 15; 9(8):821-30. PubMed ID: 10482376
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C, Winzer R, Meissner-Weigl J, Köhrle J.
    Biochem Biophys Res Commun; 1997 Nov 26; 240(3):832-8. PubMed ID: 9398654
    [Abstract] [Full Text] [Related]

  • 9. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul 26; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 10. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ.
    Cancer Gene Ther; 2003 Jan 26; 10(1):14-22. PubMed ID: 12489024
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells.
    Kogai T, Hershman JM, Motomura K, Endo T, Onaya T, Brent GA.
    Endocrinology; 2001 Aug 26; 142(8):3369-79. PubMed ID: 11459780
    [Abstract] [Full Text] [Related]

  • 13. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
    Haberkorn U.
    Exp Clin Endocrinol Diabetes; 2001 Aug 26; 109(1):60-2. PubMed ID: 11573143
    [Abstract] [Full Text] [Related]

  • 14. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N, Baker CH, Schütz M, Göke B, Morris JC, Spitzweg C.
    J Clin Endocrinol Metab; 2005 Aug 26; 90(8):4457-64. PubMed ID: 15941870
    [Abstract] [Full Text] [Related]

  • 15. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
    Haberkorn U, Beuter P, Kübler W, Eskerski H, Eisenhut M, Kinscherf R, Zitzmann S, Strauss LG, Dimitrakopoulou-Strauss A, Altmann A.
    J Nucl Med; 2004 May 26; 45(5):827-33. PubMed ID: 15136633
    [Abstract] [Full Text] [Related]

  • 16. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M.
    Eur J Endocrinol; 1999 Nov 26; 141(5):443-57. PubMed ID: 10576759
    [Abstract] [Full Text] [Related]

  • 17. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW, Shröder-van der Elst JP, Karperien M, Que I, van der Pluijm G, Goslings B, Romijn JA, van der Heide D.
    Thyroid; 2000 Nov 26; 10(11):939-43. PubMed ID: 11128720
    [Abstract] [Full Text] [Related]

  • 18. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells.
    Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, Peschke P, Kübler W, Debus J, Eisenhut M.
    J Nucl Med; 2001 Feb 26; 42(2):317-25. PubMed ID: 11216532
    [Abstract] [Full Text] [Related]

  • 19. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
    Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ.
    Cancer Gene Ther; 2000 Dec 26; 7(12):1529-36. PubMed ID: 11228531
    [Abstract] [Full Text] [Related]

  • 20. Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells.
    Chai W, Yin X, Ren L, Cai M, Long T, Zhou M, Tang Y, Yang N, Hu S.
    Clin Transl Oncol; 2015 Oct 26; 17(10):795-802. PubMed ID: 26115738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.